Chromosomal alterations in atherosclerotic plaques

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 755-761

  Matturri, Luigi ^a   Cazzullo, Alessandra ^a   Turconi, Paola ^a   Lavezzi, Anna Maria ^a   Vandone, Pier Luigi ^a   Gabrielli, Livio ^a   Fernández Alonso, Graciela ^d   Grana, Daniel ^b   Milei, José ^b,c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Cardiopsis   (Argentina)

^c UNIVERSIDAD DEL SALVADOR   (Argentina)

^d NONE

Author keywords

Atherosclerosis; Carotid artery; Chromosomal alterations; Chromosome 11; Chromosome 7; Fibroblastic growth factor 3, (FGF 3); Genetic alterations

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDARTERECTOMY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MACROPHAGE; MALE; MONOSOMY 7; MUTATION; PLOIDY; POLYSOME; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TETRASOMY; TRISOMY 7;

ADULT; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTORS; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 0035864612     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00488-3     Document Type: Article

References (33)

1. Plaque instability-the real challenge for atherosclerosis research in the next decade?
2. Carotid atherosclerosis: Immunocytochemical analysis of the vascular and cellular composition in endarterectomies
3. Carotid rupture and intraplaque hemorrhage: Immunophenotype and role of cells involved
4. Cytogenetic aspects of cell proliferation in atherosclerotic plaques
5. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway
6. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall
7. Oncogenes in atherosclerosis
8. Involvement of chromosome 7 in primary lung tumor and nonmalignant normal tissue
9. Clonal chromosome aberrations in normal kidney tissue from patients with renal cell carcinoma
10. Atherosclerotic plaque as a benign tumor?
11. The emerging concept of vascular remodeling
12. Atherosclerosis and the arterial smooth muscle cell
13. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques
14. Angiogenesis: Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions
15. Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours
16. Analysis of local gene expression in human atherosclerotic plaques by in situ hybridization
17. FISH analysis of interphase nuclei extracted from paraffin-embedded tissue
18. Nucleus extraction from single mounted tissue sections: Genetic analysis
19. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis
20. Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque
21. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells
22. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques
23. Evidence for a monoclonal origin of human atherosclerotic plaques
24. Clonal characteristics in layers of human atherosclerotic plaques
25. Apolipoprotein A I-C III-A IV deficiency
26. No association of apolipoprotein A-IV codon 347 and 360 variation with atheroesclerosis and lipid transport in a sample of mixed hyperlipidemies
27. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line
28. Angiogenesis: Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions
29. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction
30. Multiple growth factors are associated with lesion of atherosclerosis: Specificity or redundancy?
31. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty
32. Inflammatory cells, apoptosis and Chlamydia pneumoniae infection in atherosclerosis
33. The pathogenesis of atherosclerosis: A perpective for the 1990's